Quantcast

Examine Delivering Drugs By Inhalation and Emerging Therapeutic Opportunities With This Essential and Comprehensive Report

October 1, 2008

Research and Markets (http://www.researchandmarkets.com/research/45fffb/delivering_drugs_b) has announced the addition of the “Delivering Drugs by Inhalation – Emerging Therapeutic Opportunities” report to their offering.

Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. Much of the interest in pulmonary delivery of systemic drug therapies is focused on chronic diseases and refractory conditions – aliments that require frequent drug administration for a protracted period of time. The role of device design and development in defining and driving emerging opportunities in this sector cannot be overstated. Nebulizers, metered dose inhalers (MDIs), and dry powder inhalers (DPIs) have each found a niche in the quest for optimal treatment and convenient use. While nebulizers have evolved relatively independently of the drug formulations they deliver, the current generation of MDIs and DPIs have been developed or tailored for the specific pharmaceutical being delivered, resulting in improved performance. Several of the emerging drug products covered in this report will have a significant impact in the therapeutic markets they target, improving patient compliance and effectively changing the way important illnesses and conditions are treated.

 Market Data  The study presents qualitative and quantitative data and information on key market measures and benchmarks: -Inhaled Drug Delivery Market Segment size and AGR -Device-Pharma Alliance Activity and Deal Structure -Inhaled Drug Economic Factors -Strategic Positioning Factors -Industry Structure & Competitive Landscape -Combination Product Design Parameters -Third-party Stakeholders Market Participant Profiles -Market Dynamics & Sensitivities -Competitive Risks -Proprietary Technology Assessment -Self-Administration Compliance Factors -Technology Risk Factors -Regulatory Risk Factors  Forecasts and Projections cover the Period 2008-2011  Key Topics Covered:  Executive Summary  Inhaled Drug Delivery Market Dynamics -         Portrait of an Evolving Market -         Established Therapeutic Targets -         Emerging Therapies -         Demographics and Growth -         Competing Technologies -         Market Drivers -         Factors Limiting Growth  Inhalation Technology -         Drug Formulations -         Inhaler Designs -         Dry Powder Inhalers -         Metered Dose Inhalers -         Nebulizers -         Performance Factors -         Bioavailability -         Dose Reproducibility -         Active Compound Stability -         Commercial Devices -         Development-Stage Devices -         Combination Products -         Emerging Device Technologies  Inhaled Drugs - Development-stage Product Candidates -         Anaphylaxis -         Cardiovascular Medicine -         Hereditary Diseases -         Immunology -         Infectious Diseases -         Metabolic -         Growth Deficiencies -         Osteoporosis -         Neurology -         Antipsychotics -         Migraine -         Parkinson's -         Oncology -         Pain Management -         Respiratory -         Sexual Health  Market Factors -         Device Packaging -         Regulatory Issues -         Patient Compliance -         The Role of CMOs/CSOs -         Healthcare Economics  Company Profiles -         Detailed Profiles of Market Sector Participants 

For more information visit http://www.researchandmarkets.com/research/45fffb/delivering_drugs_b




comments powered by Disqus